Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice
- PMID: 20008134
- PMCID: PMC2797880
- DOI: 10.2353/ajpath.2010.090672
Tissue factor-deficiency and protease activated receptor-1-deficiency reduce inflammation elicited by diet-induced steatohepatitis in mice
Abstract
Altered hepatic lipid homeostasis, hepatocellular injury, and inflammation are features of nonalcoholic steatohepatitis, which contributes significantly to liver-related morbidity and mortality in the Western population. A collection of inflammatory mediators have been implicated in the pathogenesis of steatohepatitis in mouse models. However, the pathways essential for coordination and amplification of hepatic inflammation and injury caused by steatosis are not completely understood. We tested the hypothesis that tissue factor (TF)-dependent thrombin generation and the thrombin receptor protease activated receptor-1 (PAR-1) contribute to liver inflammation induced by steatosis in mice. Wild-type C57Bl/6J mice fed a diet deficient in methionine and choline for 2 weeks manifested steatohepatitis characterized by increased serum alanine aminotransferase activity, macrovesicular hepatic steatosis, hepatic inflammatory gene expression, and lobular inflammation. Steatohepatitis progression was associated with thrombin generation and hepatic fibrin deposition. Coagulation cascade activation was significantly reduced in low TF mice, which express 1% of normal TF levels. Hepatic triglyceride accumulation was not affected in low TF mice or PAR-1-deficient mice. In contrast, biomarkers of hepatocellular injury, inflammatory gene induction, and hepatic accumulation of macrophages and neutrophils were greatly reduced by TF-deficiency and PAR-1-deficiency. The results suggest that TF-dependent thrombin generation and activation of PAR-1 amplify hepatic inflammation and injury during the pathogenesis of steatohepatitis.
Figures







Similar articles
-
Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet.Am J Pathol. 2011 Nov;179(5):2278-89. doi: 10.1016/j.ajpath.2011.07.015. Epub 2011 Sep 9. Am J Pathol. 2011. PMID: 21907177 Free PMC article.
-
Monocyte chemoattractant protein-1 deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet.Lab Invest. 2010 Dec;90(12):1794-804. doi: 10.1038/labinvest.2010.143. Epub 2010 Aug 9. Lab Invest. 2010. PMID: 20697377 Free PMC article.
-
From the Cover: Coagulation-Driven Hepatic Fibrosis Requires Protease Activated Receptor-1 (PAR-1) in a Mouse Model of TCDD-Elicited Steatohepatitis.Toxicol Sci. 2016 Dec;154(2):381-391. doi: 10.1093/toxsci/kfw175. Epub 2016 Sep 9. Toxicol Sci. 2016. PMID: 27613713 Free PMC article.
-
Inflammation, obesity, and thrombosis.Blood. 2013 Nov 14;122(20):3415-22. doi: 10.1182/blood-2013-05-427708. Epub 2013 Oct 3. Blood. 2013. PMID: 24092932 Free PMC article. Review.
-
Tissue factor in the myocardium: evidence of roles in haemostasis and inflammation.Dis Markers. 2004;20(6):353-8. doi: 10.1155/2004/963402. Dis Markers. 2004. PMID: 15665396 Free PMC article. Review.
Cited by
-
Characterizing the Role of HMG-CoA Reductase in Aryl Hydrocarbon Receptor-Mediated Liver Injury in C57BL/6 Mice.Sci Rep. 2019 Nov 1;9(1):15828. doi: 10.1038/s41598-019-52001-2. Sci Rep. 2019. PMID: 31676775 Free PMC article.
-
Tissue factor pathways linking obesity and inflammation.Hamostaseologie. 2015;35(3):279-83. doi: 10.5482/HAMO-14-11-0068. Epub 2015 Jan 27. Hamostaseologie. 2015. PMID: 25623940 Free PMC article. Review.
-
Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis.PLoS Pathog. 2013 Mar;9(3):e1003229. doi: 10.1371/journal.ppat.1003229. Epub 2013 Mar 21. PLoS Pathog. 2013. PMID: 23555246 Free PMC article.
-
Hepatocyte-independent PAR1-biased signaling controls liver pathology in experimental obesity.J Thromb Haemost. 2024 Nov;22(11):3191-3198. doi: 10.1016/j.jtha.2024.07.017. Epub 2024 Aug 8. J Thromb Haemost. 2024. PMID: 39122189
-
Tissue factor, blood coagulation, and beyond: an overview.Int J Inflam. 2011;2011:367284. doi: 10.4061/2011/367284. Epub 2011 Sep 20. Int J Inflam. 2011. PMID: 21941675 Free PMC article.
References
-
- Clark JM, Brancati FL, Diehl AM. Nonalcoholic fatty liver disease. Gastroenterology. 2002;122:1649–1657. - PubMed
-
- Larter CZ, Yeh MM. Animal models of NASH: getting both pathology and metabolic context right. J Gastroenterol Hepatol. 2008;23:1635–1648. - PubMed
-
- Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112. - PubMed
-
- Kleiner DE, Brunt EM, Van NM, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313–1321. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous